- Acknowledgement table on the GISAID genomes used in this study[supplements/265096_file03.pdf]
- Acknowledgement table on the GISAID genomes used in this study[supplements/265096_file04.pdf]
- Acknowledgement table on the GISAID genomes used in this study[supplements/265096_file05.pdf]
- Acknowledgement table on the GISAID genomes used in this study[supplements/265096_file06.pdf]
- Acknowledgement table on the GISAID genomes used in this study[supplements/265096_file07.pdf]
- Acknowledgement table on the GISAID genomes used in this study[supplements/265096_file08.pdf]
- Acknowledgement table on the GISAID genomes used in this study[supplements/265096_file09.pdf]
- Acknowledgement table on the GISAID genomes used in this study[supplements/265096_file10.pdf]
- Acknowledgement table on the GISAID genomes used in this study[supplements/265096_file11.pdf]
- Acknowledgement table on the GISAID genomes used in this study[supplements/265096_file12.pdf]
- Acknowledgement table on the GISAID genomes used in this study[supplements/265096_file13.pdf]
- Acknowledgement table on the GISAID genomes used in this study[supplements/265096_file14.pdf]
- Acknowledgement table on the GISAID genomes used in this study[supplements/265096_file15.pdf]
- Acknowledgement table on the GISAID genomes used in this study[supplements/265096_file16.pdf]
- Acknowledgement table on the GISAID genomes used in this study[supplements/265096_file17.pdf]
- Acknowledgement table on the GISAID genomes used in this study[supplements/265096_file18.pdf]
Posted October 20, 2021.
SARS-COV-2 δ variant drives the pandemic in India and Europe via two subvariants
